Comparison timestamp: 2025-05-04 10:05:53 UTC
RestoredCDC URL: http://restoredcdc.org/www.cdc.gov/nhsn/faqs/faqs-miscellaneous.html
Live cdc.gov URL ↗: https://www.cdc.gov/nhsn/faqs/faqs-miscellaneous.html
RestoredCDC URL: http://restoredcdc.org/www.cdc.gov/nhsn/faqs/faqs-miscellaneous.html
Live cdc.gov URL ↗: https://www.cdc.gov/nhsn/faqs/faqs-miscellaneous.html
Removed: Line removed from cdc.gov. Specific word removals are highlighted.
Added: Line added to cdc.gov. Specific word additions are highlighted.
Injected:
Line or disclaimer added by RestoredCDC.org.
Unchanged: Line unchanged.
Original site: www.cdc.gov/nhsn/faqs/faqs-miscellaneous.html | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.[More]About Us Report Bug Compare ContentSkip directly to site content Skip directly to searchEspañol | Other LanguagesHere's how you knowAn official website of the United States government Here's how you knowNational Healthcare Safety Network (NHSN)National Healthcare Safety Network (NHSN)Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People National Healthcare Safety Network (NHSN)SearchSearch Menu Navigation Menu× Search NHSNSearch NHSN All CDCSubmitNational Healthcare Safety Network (NHSN)* NHSN Login* About NHSN+ BACKAbout NHSN+ NHSN’s Stated Purposes+ About NHSN Help Desk+ NHSN Administrator Training+ Data Use Agreements (DUA) with NHSN+ DUA FAQs for Health Departments and Facilities+ FAQs About NHSN Agreement to Participate and Consent+ NHSN Release Management+ FAQs About NHSN+ About SAMS+ SAMS NHSN User FAQs+ FAQs About NHSN Security+ National Healthcare Safety Network (NHSN) Home* Enroll Facility Here+ BACKEnroll Facility Here+ Acute Care Hospitals/Facilitieso BACKAcute Care Hospitalsspan>Acute Care Hospitals/Facilitieso BACKEnroll Facility Here Acute Care Hospitalsspan>Enroll Facility Here Acute Care Hospitals/Facilitieso Set-upo National Healthcare Safety Network (NHSN) Home+ Ambulatory Surgery Centerso BACKAmbulatory Surgery Centerso BACKEnroll Facility Here Ambulatory Surgery Centerso Set-upo National Healthcare Safety Network (NHSN) Home+ Blood Safety Surveillanceo BACKBlood Safety Surveillanceo BACKEnroll Facility Here Blood Safety Surveillanceo Set-upo National Healthcare Safety Network (NHSN) Home+ Long-term Acute Care Facilitieso BACKLong-term Acute Care Facilitieso BACKEnroll Facility Here Long-term Acute Care Facilitieso Set-upo National Healthcare Safety Network (NHSN) Home+ Inpatient Rehabilitation Facilitieso BACKInpatient Rehabilitation Facilitieso BACKEnroll Facility Here Inpatient Rehabilitation Facilitieso Set-upo National Healthcare Safety Network (NHSN) Home+ Inpatient Psychiatric Facilitieso BACKInpatient Psychiatric Facilitieso BACKEnroll Facility Here Inpatient Psychiatric Facilitieso Set-upo National Healthcare Safety Network (NHSN) Home+ Long-term Care Facilitieso BACKLong-term Care Facilitieso BACKEnroll Facility Here Long-term Care Facilitieso Set-upo National Healthcare Safety Network (NHSN) Home+ Outpatient Dialysis Facilitieso BACKOutpatient Dialysis Facilitieso BACKEnroll Facility Here Outpatient Dialysis Facilitieso Set-upo National Healthcare Safety Network (NHSN) Home+ Home Dialysis Facilities+ FAQs About Enrollment+ National Healthcare Safety Network (NHSN) Home* CMS Requirements+ BACKCMS Requirements+ Acute Care Hospitals (ACH)+ Inpatient Rehabilitation Facilities (IRF)+ Long-term Acute Care Facilities (LTACH)+ Long-term Care Facilities+ PPS Exempt Cancer Hospitals+ Outpatient Dialysis Facilities+ CDC and CMS Issue Joint Reminder on NHSN Reporting+ FAQs About CMS Quality Reporting Programs+ FAQs About CMS Promoting Interoperability Program+ FAQs About NHSN and CMS ESRD QIP Rule+ National Healthcare Safety Network (NHSN) Home* Change NHSN Facility Admin* Resources by Facility+ BACKResources by Facility+ COVID-19 Informationo BACKCOVID-19 Informationo BACKResources by Facility COVID-19 Informationo Hospital Respiratory Data Dashboardo Nursing Home Vaccination Data Dashboardo Nursing Home Data Dashboardo Dialysis COVID-19 Data Dashboardo Dialysis Vaccination Data Dashboardo FAQs on Transition of COVID-19 Hospital Reportingo Archived COVID-19/Respiratory Pathogens and Vaccination Materialso National Healthcare Safety Network (NHSN) Home+ Acute Care / Critical Access Hospitals+ Ambulatory Surgery Centerso BACKAmbulatory Surgery Centerso BACKResources by Facility Ambulatory Surgery Centerso Newsletters & Archived Communicationso National Healthcare Safety Network (NHSN) Home+ Long-term Acute Care Hospitals+ Inpatient Rehabilitation Facilities+ Inpatient Psychiatric Facilities+ National Healthcare Safety Network (NHSN) Home* Patient Safety Component+ BACKPatient Safety Component+ Nurse Staffing Hours Indicator+ Annual Surveys, Locations & Monthly Reporting Plans+ Analysis Resourceso BACKAnalysis Resourceso BACKPatient Safety Component Analysis Resourceso Analysis Quick Reference Guideso Adjusted Ranking Metric (ARM)o Keys to Success with the SIRo Keys to Success with the SAARo Keys to Success with TASo Data Qualityo National Healthcare Safety Network (NHSN) Home+ HAI Rebaselineo BACKHAI Rebaselineo BACKPatient Safety Component HAI Rebaselineo Charting the Courseo Progress Trackero Education & Analysis Resourceso Archived Communicationso National Healthcare Safety Network (NHSN) Home+ Antimicrobial Use & Resistanceo BACKAntimicrobial Use & Resistanceo BACKPatient Safety Component Antimicrobial Use & Resistanceo AU Option Case Examples- BACKAU Option Case Examples- BACKAntimicrobial Use & Resistance AU Option Case Examples- BACKPatient Safety Component Antimicrobial Use & Resistance AU Option Case Examples- Disseminating Quarterly Data Quality Reports- Tracking Multiple Interventions- Reducing Fluoroquinolone Use- Reducing Carbapenem Use- Reducing Aztreonam Use- National Healthcare Safety Network (NHSN) Homeo National Healthcare Safety Network (NHSN) Home+ BSI (CLABSI)+ CLIP+ MDRO & CDI+ PedVAE+ PNEU+ SSI+ UTI (CAUTI)+ VAE+ Frequently Asked Questions (FAQs)o BACKFrequently Asked Questions (FAQs)o BACKPatient Safety Component Frequently Asked Questions (FAQs)o Annual Surveyso Bloodstream Infection (BSI) Eventso Central Line Insertion Practices (CLIP)o Pneumonia (PNEU) Eventso Urinary Tract Infection (UTI) Eventso Surgical Site Infections (SSI) Eventso Surgical Site Procedure Codeso Ventilator-Associated (VAE) Eventso Pediatric Ventilator-Associated Events (PedVAE)o Antimicrobial Use (AU) Optiono Antimicrobial Resistance (AR) Optiono MDRO & CDIo Nurse Staffing Hours Indicator (NSHI)o Analysiso Locationso Miscellaneouso National Healthcare Safety Network (NHSN) Home+ Calculators & Worksheetso BACKCalculators & Worksheetso BACKPatient Safety Component Calculators & Worksheetso HAI & POA Worksheet Generatoro MDRO & CDI LabID Event Calculatoro PedVAE Calculatoro VAE Calculatoro National Healthcare Safety Network (NHSN) Home+ HAI Checklists+ Hospital Respiratory Data+ National Healthcare Safety Network (NHSN) Home* Long-term Care Facility Component+ BACKLong-term Care Facility Component+ Respiratory Pathogens and Vaccination Module+ Respiratory Pathogens Moduleo BACKRespiratory Pathogens and Vaccination ModuleRespiratory Pathogens Moduleo BACKLong-term Care Facility Component Respiratory Pathogens and Vaccination ModuleLong-term Care Facility Component Respiratory Pathogens Moduleo Covid-19 Module Enrollmento Point of Careo RPV Resourceso RP Resourceso National Healthcare Safety Network (NHSN) Home+ Nursing Home Data Dashboard+ State Veterans Homes COVID-19 Tool+ MDRO & CDI+ UTI+ Prevention Process Measures+ HCP Flu Vaccination+ LTCF Data Validation Guidance+ Newsletters & Archived Communicationso BACKNewsletters & Archived Communicationso BACKLong-term Care Facility Component Newsletters & Archived Communicationso December 2020 LTCF Newslettero July 2020 LTCF Newslettero March 2020 LTCF Newslettero December 2019 LTCF Newslettero September 2019 LTCF Newslettero June 2019 LTCF Newslettero March 2019 LTCF Newslettero 2018 LTCF Email Updateso December 2018 LTCF Newslettero September 2018 LTCF Newslettero June 2018 LTCF Newslettero March 2018 LTCF Newslettero 2017 LTCF Email Updateso December 2017 LTCF Newslettero September 2017 LTCF Newslettero National Healthcare Safety Network (NHSN) Home+ National Healthcare Safety Network (NHSN) Home* Dialysis Component+ BACKDialysis Component+ Dialysis COVID-19 Module+ Patient COVID-19 Vaccination+ Dialysis Evento BACKDialysis Evento BACKDialysis Component Dialysis Evento Dialysis Event Reporting FAQso National Healthcare Safety Network (NHSN) Home+ Prevention Process Measures+ CLIP Adherence+ Monthly Newsblast Archive+ National Healthcare Safety Network (NHSN) Home* Biovigilance Component+ BACKBiovigilance Component+ Blood Safety+ Hemovigilance Module FAQs+ National Healthcare Safety Network (NHSN) Home* Healthcare Personnel Safety Component (HPS)+ BACKHealthcare Personnel Safety Component (HPS)+ HCP Flu Vaccination+ HCP Exposure+ HCP COVID-19 Vaccination+ COVID-19 Vaccination Data FAQs+ Weekly Influenza Vaccination Data Reporting FAQs+ HCP Influenza Vaccination Summary Reporting FAQso BACKHCP Influenza Vaccination Summary Reporting FAQso BACKHealthcare Personnel Safety Component (HPS) HCP Influenza Vaccination Summary Reporting FAQso Newsletters & Archived Communicationso National Healthcare Safety Network (NHSN) Home+ National Healthcare Safety Network (NHSN) Home* Neonatal Component+ BACKNeonatal Component+ Quick Reference Guides+ LOS/MEN Events+ LOS/MEN FAQs+ National Healthcare Safety Network (NHSN) Home* Outpatient Procedure Component+ BACKOutpatient Procedure Component+ SSI+ Same Day Outcome Measures+ Frequently Asked Questions (FAQs)+ Newsletters & Archived Communications+ National Healthcare Safety Network (NHSN) Home* NHSN and Social Determinants of Health* NHSNCoLab* NHSN Digital Quality Measures (dQMs)+ BACKNHSN Digital Quality Measures (dQMs)+ About FHIR and NHSNLink+ Digital Quality Measures (dQMs) FAQs+ National Healthcare Safety Network (NHSN) Home* NHSN Reports+ BACKNHSN Reports+ Coronavirus Disease - 2019 (COVID-19)+ HAI Progress Reports+ HAI Pathogens and Antimicrobial Resistance (AR)+ Antibiotic Use and Resistance (AUR) Module+ Long-term Care Facility (LTCF)+ Patient Safety Annual Facility Survey+ Device-Associated (DA) Module Data Summary+ HCP Influenza Vaccination+ Dialysis Event+ Miscellaneous+ National Healthcare Safety Network (NHSN) Home* Group Users* Newsletters* Data Validation Guidance+ BACKData Validation Guidance+ 2023+ 2022+ 2021+ Validation FAQs+ Archived Validation Documents+ National Healthcare Safety Network (NHSN) Home* Email Updates* Quality Measure Endorsement* HIPAA Privacy Rule+ BACKHIPAA Privacy Rule+ Facility/Provider Communications Under HIPAA+ National Healthcare Safety Network (NHSN) Home* National Healthcare Safety Network (NHSN) HomeNational Healthcare Safety Network (NHSN)National Healthcare Safety Network (NHSN) HomeCDC's website is being modified to comply with President Trump's Executive Orders.FAQs: MiscellaneousMiscellaneousOn This Page* HAI in patients awaiting organ harvest* POA & RIT* Rationale for definition of healthcare-associated infection (HAI)* POA or HAI* Surveillance vs. Clinical* What are considered diagnostic tests* Diagnostic tests* Non-culture based microbiologic testing* Active Surveillance Culture/Testing (ASC/AST)* In-plan vs. off-plan NHSN reporting* Facilities that share a CCN* Positive surveillance screening and HAI* Temperature (Fever)* Temperature measurement* Vital signs* Patient identification* Observation patients & denominator counts* Observation patients & surveillance/denominator counts* Observation patients, swing bed patients, or hospice patients in inpatient units* Mixed-acuity units* Location codes* Physician diagnosis* Differing documentation* Counting device days* Device counts* Broth only cultures* NHSN requirements and recommendation for application use* Gross anatomical* Imaging test findings* Pathogen reporting in NHSN* Protocols for Patient Safety Component Modules* Event detail – With no other recognized causeHAI in patients awaiting organ harvestQ1. Do we need to report an HAI in a patient who is being supported for the purpose of organ harvest?If the date of specimen collection is on or after the date of documentation of evidence of consent AND the patient is being supported for organ donation purposes, an event identified using the specimen culture result or microbiologic non-culture based diagnostic test result should not be reported as an HAI. For criteria without a specimen collected, if the date of event (DOE) is on or after the date of documentation of evidence of consent AND the patient is being supported for organ donation purposes, the event identified should not be reported as an HAI. The patient should, however, still be included in device and patient day denominator data collection.POA & RITQ2. Does the Repeat Infection Timeframe (RIT) apply to Present on Admission (POA) infections?Q1. Does the Repeat Infection Timeframe (RIT) apply to Present on Admission (POA) infections?Yes. The repeat infection timeframe (RIT) is set by the date of event (DOE). For surveillance purposes a POA infection may only have a DOE on the day of admission or the next day. If the first element within the infection window period (IWP) occurred in the 2 days before admission, the DOE is considered the day of admission. The RIT is the 14-day time period where no new infections of the same type are reported, beginning with the date of event.Yes. The repeat infection timeframe (RIT) is set by the date of event (DOE). For surveillance purposes a POA infection may only have a DOE on the day of admission to an inpatient location or the next day. If the first element within the infection window period (IWP) occurred in the 2 days before admission, the DOE is considered the day of admission to an inpatient location. The RIT is the 14-day timeframe where no new infections of the same type are reported, beginning with the date of event.Example: A UTI with E. coli identified with DOE on the day of admission is considered POA. If 10 days later a new urine culture shows K. pneumonia >100,000 CFU/ml, then the organism is added to the original UTI (no new event is cited but rather is considered a continuation of the original event). The UTI RIT remains Hospital Days 1-14.Example: A symptomatic UTI (SUTI) with E. coli identified with DOE on the day of admission is considered POA. If 10 days later a new SUTI with K. pneumonia is identified, then the K. pneumonia is added to the original UTI. The UTI RIT remains Hospital Days 1-14.NOTE: If a patient is admitted with a POA BSI and subsequent blood specimens are collected, the POA BSI must be identified as either primary or secondary in nature. A primary POA BSI will set a BSI RIT. However, a POA BSI that is secondary to another site of infection will NOT set a BSI RIT. It will only set an RIT for the type of infection to which the BSI is secondary. Please see the article on page 3 of the September 2015 NHSN Newsletter for more details. September 2015 NHSN Newsletter [PDF – 2 MB] .NOTE: If a patient is admitted with a POA BSI and subsequent blood specimens are collected, the POA BSI must be identified as either primary or secondary in nature. A primary POA BSI will set a BSI RIT. However, a POA BSI that is secondary to another site of infection will NOT set a BSI RIT. It will only set an RIT for the type of infection to which the BSI is secondary .Rationale for definition of healthcare-associated infection (HAI)Q2. How do I determine if an infection is present on admission or healthcare-associated?Q3. Can you please explain the rationale for the definition of healthcare-associated infection (HAI) vs. an infection that was present on admission (POA)?Several studies have demonstrated there was subjective application of the NHSN HAI surveillance definitions by different IPs and facilities, prior to 2013. During this time, the NHSN definitions allowed facilities to subjectively determine evidence that an infection was present or incubating on admission, which was not reportable to NHSN because it was not “healthcare-associated”. Subjectivity, providing an opportunity for inconsistent data collection, must be removed from surveillance definitions whenever possible. With this in mind, CDC and the HICPAC surveillance working group, a group made up of infectious disease professionals, healthcare epidemiologists, infection preventionists, and state public health representatives, developed a set of objective surveillance criteria to be implemented into NHSN and used by all facilities reporting data to NHSN. Through the use of the same set of objective criteria it is expected that data reported to the system is useful for quality improvement activities.POA or HAIQ4. How do I determine if an infection is present on admission or healthcare-associated?For infections of all types except VAE, PedVAE, SSI, LabID Event, to make a proper determination regarding a possible healthcare-associated infection, proceed in this order:1. First, determine the date of the diagnostic test that is an element of the NHSN site-specific infection criterion that is met.2. Next determine the infection window period (3 days before the diagnostic test, the day of the test, and 3 days after for a total of 7 days). NOTE : when the diagnostic test used to set the IWP is hospital day 3 or earlier, the days before the diagnostic test can only include those that occur in the POA timeframe, specifically the 2 days prior to admission.3. Then determine if all of the elements of the criterion are met during the infection window period. If they are, there is an infection event. If they are not, there is no event.4. If there is an event, next determine the date of event, specifically, the date that the first element used to meet the infection criterion occurs for the first time within the infection window period.5. Is the date of event in the POA timeframe (specifically, during the 2 days before admission, the day of admission, or the next day)? If yes, the infection is POA; if not, it is an HAI. Please note, when assigning a repeat infection timeframe (RIT) for a POA event, if the date of event is determined to be either of the two days prior to inpatient admission then the date of event, and therefore day 1 of the RIT, is considered hospital day 1.2. Next determine the infection window period (3 days before the diagnostic test, the day of the test, and 3 days after for a total of 7 days). NOTE: when the diagnostic test used to set the IWP is hospital day 3 or earlier, the days before the diagnostic test can only include those that occur in the POA timeframe, specifically the 2 days prior to admission.Chapter 2 of the NHSN PSC Manual – Identifying HAI for NHSN Surveillance provides guidance and examples. Please see:http://www.cdc.gov/nhsn/PDFs/pscManual/2PSC_IdentifyingHAIs_NHSNcurrent.pdf3. Then determine if all of the elements of the criterion are met during the infection window period. If they are, there is an infection event. If they are not, there is no event.4. If there is an event, next determine the date of event, specifically, the date that the first element used to meet the infection criterion occurs for the first time within the infection window period.5. Is the date of event in the POA time period (specifically, during the 2 days before admission, the day of admission, or the next day)? If yes, the infection is POA; if not, it is an HAI. Please note, when assigning a repeat infection timeframe (RIT) for a POA event, if the date of event is determined to be either of the two days prior to inpatient admission then the date of event, and therefore day 1 of the RIT, is considered hospital day 1.Chapter 2 of the NHSN PSC Manual – Identifying HAI for NHSN Surveillance provides guidance and examples. Please see: Chapter 2 of the NHSN PSC Manual – Identifying HAI for NHSN Surveillance [PDF – 1 MB] .Surveillance vs. ClinicalQ5. What is the difference between a surveillance definition of an infection and a clinical diagnosis? My physician states that a patient is not infected although the patient clearly meets the NHSN HAI criteria. How do I respond?Q3. What is the difference between a surveillance definition of an infection and a clinical diagnosis? My physician states that a patient is not infected although the patient clearly meets the NHSN infection criterion. How do I respond?Surveillance definitions are designed to study and identify trends in a population. The application of these standardized criteria, and only these criteria, in a consistent manner allows confidence in aggregation and analysis of data. Alternatively, clinical diagnoses are patient specific. Unlike surveillance definitions, ALL available diagnostic data are considered in a clinical diagnosis, including additional clinical, epidemiological and laboratory data not used for NHSN surveillance. Therefore, a clinical diagnosis may be made even when a surveillance definition may not be met and vice versa is also true. Failure to meet a surveillance definition should never impede or override clinical judgment during diagnosis, management, or treatment of patents. Nor should failure to meet clinical definitions result in non-reporting to NHSN infections meeting the NHSN surveillance criteria.Surveillance definitions are designed to study and identify trends in a population . The application of these standardized criteria, and only these criteria , in a consistent manner allows confidence in aggregation and analysis of data. Alternatively, clinical diagnoses are patient specific. Unlike surveillance definitions, ALL available diagnostic data are considered in a clinical diagnosis, including additional clinical, epidemiological , and laboratory data not used for NHSN surveillance. Therefore, a clinical diagnosis may be made even when a surveillance definition may not be met or vice versa Failure to meet a surveillance definition should never impede or override clinical judgment during diagnosis, management, or treatment of patents. Nor should failure to meet clinical definitions result in non-reporting to NHSN infections meeting the NHSN surveillance criteria.What are considered diagnostic testsDiagnostic testsQ6. What are considered diagnostic tests for the purpose of defining the infection window period and date of event?Q4. What are acceptable diagnostic tests for the purpose of defining the infection window period and date of event?The following are considered diagnostic tests only when they are an element of the criteria that is met:* Laboratory specimen collection* Imaging test* Procedure or examNon-culture based microbiologic testingQ7. In the NHSN HAI definitions, what is meant by the term “non-culture based microbiologic testing method which is performed for purposes of clinical diagnosis and treatment (for example, not Active Surveillance Culture/Testing (ASC/AST)”?Q5. In the NHSN surveillance definitions, what is meant by the term “non-culture based microbiologic testing method which is performed for purposes of clinical diagnosis and treatment (for example, not Active Surveillance Culture/Testing [ASC/AST])”?This term refers to the identification of microorganisms using a method of testing other than a culture. Culture based testing requires inoculation of a specimen to culture media, incubation, and observation for actual growth of microorganisms. Depending on the organism identified, culturing can take several days to weeks for a final report. In contrast, non-culture-based testing (NCT) methods generally provide faster results, which can assist with early diagnosis and tailoring of antimicrobial therapy. Examples of non-culture-based testing include, but are not limited to, PCR (polymerase chain reaction) and ELISA (Enzyme-linked immunosorbent assay) as well as DNA sequencing.This term refers to the identification of microorganisms using a method of testing other than a traditional culture. Culture based testing requires inoculation of a specimen to culture media, incubation, and observation for actual growth of microorganisms. Depending on the organism identified , culturing can take several days to weeks for a final report. In contrast, non- culture-based testing (NCT) methods generally provide faster results, which can assist with early diagnosis and tailoring of antimicrobial therapy. Examples of non- culture-based testing include, but are not limited to, PCR (polymerase chain reaction) and ELISA (Enzyme-linked immunosorbent assay) as well as DNA sequencing. NCT is defined as a methodology that identifies an organism directly from a specimen without inoculation of the specimen to any culture media. For instance, NCT does not include identification by PCR of an organism grown on any other culture media prior to performing PCR testing.Active Surveillance Culture/Testing (ASC/AST)Q8. What is meant by the term Active Surveillance Culture/Testing?Q6. What is meant by the term Active Surveillance Culture/Testing?For purposes of NHSN surveillance, Active Surveillance Culture/Testing (ASC/AST) refers to testing that is intended to identify the presence/carriage of microorganisms for the purpose of instituting or discontinuing isolation precautions (for example, nasal swab for MRSA, rectal swab for VRE), or monitoring for eradication of a carrier state. ASC/AST does NOT include identification of microorganisms with cultures or tests performed for diagnosis and treatment purposes (for example, specimens collected from sterile body sites, including blood specimens).For purposes of NHSN surveillance, Active Surveillance Culture/Testing (ASC/AST) refers to testing that is intended to identify the presence/carriage of microorganisms for the purpose of instituting or discontinuing isolation precautions or monitoring for eradication of a carrier state. ASC/AST does NOT include identification of microorganisms with cultures or tests performed for diagnosis and treatment purposes (for example, specimens collected from sterile body sites , including blood specimens) . Common examples of ASC/AST include nasal swabs for detection of MRSA and rectal swabs for detection of VRE or C. difficile .In-plan vs. off-plan NHSN reportingQ7. A patient is admitted and is MRSA-positive by admission screening, then develops an infection with MRSA. Is that infection a healthcare-associated infection (HAI)?Q9. What is the meaning of "in-plan" and "off-plan" surveillance for NHSN surveillance?A positive screening culture at admission will not meet an NHSN infection criteria. If the patient meets an NHSN surveillance definition on or after HD 3, an HAI is reported.“In plan” surveillance is surveillance which a facility has indicated in their NHSN Monthly Reporting Plan (MRP) will be performed. By including the data in the NHSN MRP, the facility is stating that the NHSN surveillance protocol(s) will be used, in its entirety, for that particular event. Only in-plan data are submitted to CMS in accordance with CMS’s Quality Reporting Programs. Only data that are entered into NHSN “in-plan” are included in NHSN annual reports or other NHSN publications.Facilities that share a CCNQ10. Do separate facilities that share a single CCN (CMS certification number) need to enroll separately in NHSN?Q8 My healthcare system has several facilities that share a single CCN (CMS certification number). Do I report the data separately for each facility into NHSN?If the facilities are physically separate buildings from each other, whether on the same property or over multiple campuses, then they should be enrolled separately in NHSN. Each facility should have its own, unique NHSN OrgID. When a CCN is shared across multiple facilities, the CDC will aggregate the data from all applicable NHSN OrgIDs and will send to CMS under the single CCN for CMS reporting purposes. Each distinct facility should monitor HAIs and prevention efforts separately, for the purposes of accurate tracking and targeted infection control.The CCN does not define NHSN enrollment. F acilities located in physically separate locations should be enrolled individually in NHSN with a unique NHSN identifier (NHSN orgID ) . If there are several different buildings on the same campus but physically connected (underground tunnel, co nnecting corridors etc.) and all buildings are a part of the same facility, only a single NHSN identifier is assigned to cover all buildings. W hen a CCN is shared across multiple facilities, the CDC will aggregate the data from all applicable NHSN Org IDs and will send data to CMS under the single CCN for CMS reporting purposes. Additionally, each distinct facility’s data is analyzed individually to facilitate HAI monitoring and prevention efforts at the facility level for the purposes of accurate tracking and targeted infection control.Positive surveillance screening and HAIQ11. A patient is admitted and is MRSA-positive by admission screening, then develops an infection with MRSA. Is that infection a healthcare-associated infection (HAI)?A positive screening culture at admission does not mean that any subsequent infection with that organism is not a healthcare-associated infection (HAI). Many HAIs are caused by organisms from endogenous patient sources and prevention efforts may be employed to prevent these organisms from causing an HAI. A positive screening culture without evidence of infection usually represents colonization NOT incubation. Unless such a patient meets all other required criteria to fulfill the present on admission (POA) definition, no POA infection is identified.Temperature (Fever)Q12. If present, should a fever be applied to criteria of more than one type of HAI, or can it be determined that the fever is due to one type of infection but not another? For instance, can a fever be deemed due to a pneumonia (PNEU) but not a coincidental urinary tract infection (UTI)?Q9. If present, should a fever be applied to criteria of more than one type of HAI, or can it be determined that the fever is due to one type of infection but not another? For instance, can a fever be deemed due to a pneumonia (PNEU) but not a concurrent urinary tract infection (UTI)?Because fever is a non-specific sign of infection, it is possible that an individual may run a fever due to more than one infection at a time. It would be impossible to determine which infection (if not both) was the cause of the fever. Therefore, in this example, if all other criteria besides fever are met, the patient would have both an NHSN PNEU and an NHSN UTI. This process negates the use of clinical, subjective decision making to determine NHSN HAI events.Temperature measurementQ13. Is there a standard or recommendation regarding the use of, or the conversion of, axillary temperature readings to an oral or core equivalent?Q10. Is there a standard or recommendation regarding the use of, or the conversion of, axillary temperature readings to an oral or core equivalent?The issue of the route of temperature measurement was considered here at NHSN and a decision was made to forego requiring a certain route of measurement, since our aim is not to direct care, but rather to measure the effect of care on outcomes. A detailed literature search was performed and subject matter experts consulted regarding the many routes of measurement and what they may mean when compared to others. The final determination was that there are no research-based guidelines concerning converting temperatures based on route of measurement. When using fever as an element of an NHSN infection criterion, use the temperature documented in the patient’s medical record (no conversion of temperature based on route of collection).The issue of the route of temperature measurement was considered here at NHSN and a decision was made to forego requiring a certain route of measurement, since our aim is not to direct care, but rather to measure the effect of care on outcomes . A detailed literature search was performed, and subject matter experts were consulted regarding the many routes of temperature measurement and what they may mean when compared to others . The final determination was that there are no research-based guidelines concerning converting temperatures based on route of measurement . When using fever as an element of an NHSN infection criterion, use the temperature documented in the patient’s medical record (no conversion of temperature based on route of collection).Vital signsQ14. How do we determine if a patient has an abnormal vital sign when it is not concretely defined in NHSN, for example, “bradycardia” in the LCBI 3 criterion?Q11. How do we determine if a patient has an abnormal vital sign when it is not concretely defined in NHSN?If a specific value for a vital sign is not stated in a CDC/NHSN HAI definition criterion (for example bradycardia, hypotension), the facility should use the vital sign parameters as stated in its own policies and procedures for clinical practices. Additionally, documentation of these conditions in the medical chart may also be used, for example, “…patient is hypotensive” would satisfy the element of “hypotension.”If a specific value for a vital sign is not stated in a CDC/NHSN HAI definition criterion (for example, hypotension), the facility should use the vital sign parameters as stated in its own policies and procedures for clinical practices . Additionally, documentation of these conditions in the medical chart may also be used, for example, “…patient is hypotensive” would satisfy the element of “hypotension . ”Patient identificationQ15. Which Patient ID should be used when reporting data to NHSN: the visit/account number or the medical record number?Q12. Which Patient ID should be used when reporting data to NHSN: the visit/account number or the medical record number?The patient ID is the key identifier in NHSN for each facility. Therefore, the patient ID should be an identifier that remains constant for the patient on any subsequent visits; oftentimes, this is the medical record number. The use of an identifier that changes with each visit to the facility, for example, would result in the inability to link an SSI to a procedure, as well as inappropriate assignment and calculation of LabID events and subsequent measures.Observation patients & denominator countsObservation patients & surveillance/denominator countsQ16. Are observation patients housed in an inpatient location included in the location's surveillance?Q13. Are observation patients, swing bed patients, or hospice patients housed in an inpatient location included in the location's HAI surveillance, unit denominator counts, and LabID event surveillance?For determining accurate device and/or patient day counts in inpatient locations, any patient present in an inpatient location at the time of the count(s) should be included, regardless of whether they spend the night. The facility’s designation of a patient as “inpatient” is not necessary to meet the NHSN inpatient definition.Yes, all patients housed in an inpatient location are included in HAI surveillance , denominator data collection , and LabID event surveillance for the inpatient location . The facility’s designation of a patient as ‘ obs e rvation , swing bed , or hospice’ will not exclude them from standard surveillance activities for the unit .Observation patients, swing bed patients, or hospice patients in inpatient unitsQ17. Should observation patients, swing bed patients, or hospice patients housed in an inpatient unit be included in our HAI and inpatient LabID event surveillance efforts?Yes. All patients residing in an inpatient unit should be included in the surveillance efforts for that unit regardless of the facility’s categorization as “observation” or “hospice” patient (including patients being provided only palliative or supportive care), or that they are in a swing bed within an inpatient location.Mixed-acuity unitsQ18. Our critical care unit is actually both a medical critical care and step-down unit because we don't have a step-down unit in our hospital. So, would the location designation for this type of unit be "Mixed Acuity" ward and if "yes," would CLABSIs in this location need to be reported for participation in the Centers for Medicare and Medicaid Services’ (CMS) Hospital Inpatient Quality Reporting Program?The designation of Mixed Acuity Unit should be used only when both of the following are true:* Less than 80% of the patients are of the same acuity level, for example, critical care, step down, or ward level;AND* “Virtual” locations cannot be set up within NHSN to identify groups of patients of the same acuity levels.Use of virtual locations requires the ability to identify separate patient days and device days for these groups of patients. Correct mapping of facility locations is vital for appropriate comparison and calculation of device-associated SIRs. Detailed guidance can be found at http://www.cdc.gov/nhsn/PDFs/pscManual/15LocationsDescriptions_current.pdf [PDF – 677 KB] . For CMS IPPS reporting, CLABSI reporting is mandatory for adult & pediatric ICUs, medical wards, surgical wards, and combined medical/surgical wards as well as neonatal ICUs for acute care facilities. Long-Term Acute Care facilities are required to report CLABSIs for all inpatient locations. The data that NHSN shares with CMS will not include data for locations mapped as Mixed Acuity Units. For more details regarding the reporting requirements for CMS Quality Reporting Programs, as they pertain to NHSN surveillance, please visit: CMS Requirements.Location codesQ19. How do I know if I have my location codes set-up correctly?Please refer to the guidance that is provided in the CDC Locations and Descriptions Chapter (Chapter 15). The beginning of this chapter offers a guide which will help you set up your locations properly. CDC Locations and Descriptions Chapter (Chapter 15) [PDF – 1 MB]Physician diagnosisQ20. Can physician diagnosis be used to identify an infection that is present on admission to the facility?Q14. Can physician diagnosis be used to identify an infection that is present on admission to the facility?Only if physician diagnosis is a part of an NHSN site-specific infection criteria may it be used in the determination that an infection was present on admission (POA). For example, since the BSI criteria do not include physician diagnosis as part of the criteria, a physician documentation of BSI cannot be used to meet CDC/NHSN criteria for a BSI. As a reminder, the date of event of a CDC/NHSN site-specific infection criterion must occur within the POA time period (specifically the 2 days before admission, the day of admission, or the day after admission) for the infection to be considered present on admission. This is regardless of admitting diagnosis or treatments the patient may be receiving upon admission (for example, antibiotics).Only if physician diagnosis is a part of an NHSN site-specific infection criteri on may it be used in the determination that an infection was present on admission (POA). For example, since the BSI criteria do not include physician diagnosis as part of the criteria, a physician documentation of BSI cannot be used to meet CDC/NHSN criteria for a BSI . As a reminder, the date of event of a CDC/NHSN site-specific infection criterion must occur within the POA timeframe (specifically the 2 days before admission, the day of admission , or the day after admission ) for the infection to be considered present on admission. This is regardless of admitting diagnosis or treatments the patient may be receiving upon admission (for example, antibiotics).Differing documentationQ15: Does NHSN consider differing documentation eligible for use with NHSN infection criterion? What if a culture is labeled incorrectly?NHSN takes documentation at face value and of equal value; any evidence of infection documented in the patient record is eligible for use with NHSN criteria. For example, if there is documented purulence on HD 4 and ‘no purulence noted’ documented HD 5, the HD 4 documentation is eligible for use with infection criteria . The subsequent documentation doesn’t cancel out/negate using the first documentation . NHSN can’t adjudicate differences in documentation or differences in labeling of cultures . If there is a discrepancy in culture collection and culture label, it is left to the facility to clarify conflicting documentation and decide which documentation reflects findings accurately.Counting device daysQ21. How are partial device days or single day vacations from medical devices handled when determining if a device has been in place for the minimum > 2 calendar days on the date of event and the infection therefore device-associated?Q16. How are partial device days or single day vacations from medical devices handled when determining if a device has been in place for the minimum > 2 calendar days on the date of event and the infection therefore device-associated?If a device is present for any part of a calendar day, then that day contributes to the minimum day requirement for the device-associated infection. Examples include when a device is removed and then reinserted on that calendar day or the next. If instead, a full calendar day passes without device presence, then the day count begins anew for device days if the device is reinserted. An example is the removal of a device on Monday, without reinsertion until Wednesday or later.If a device is present for any part of a calendar day, then that day contributes to the minimum day requirement for the device-associated infection. Examples include when a device is removed and then reinserted on that calendar day or the next . If instead, a full calendar day passes (not to be read as 24 hours) without device presence, then the day count begins anew for device days if the device is reinserted. An example is the removal of a device on Monday, without reinsertion until Wednesday or later.Device countsQ22. Do I need to do daily device counts to collect device days?Q17. Do I need to do daily device counts to collect device days?Denominator data are collected at the same time, every day, per location. Alternatively, a denominator sampling method can be used where the number of patients in the location (patient days) and the number of patients with an indwelling device (urinary catheter/central line/ventilator) is collected on a designated day each week at the same time. For accuracy, do not use Saturday or Sunday for sampling purposes and only non-oncology ICUs and wards with an average of 75 or more device days per month in the previous year are eligible to use this method. When using this method, the patient days must also be counted each day of the week.Denominator data are collected at the same time, every day, per location . Alternatively, a denominator sampling method can be used where the number of patients in the location (patient days) and the number of patients with an indwelling device (urinary catheter/central line/ventilator) is collected on a designated day each week at the same time . For accuracy, do not use Saturday or Sunday for sampling purposes and only non-oncology ICUs and wards with an average of 75 or more device days per month in the previous year are eligible to use this method . When using this method, the patient days must also be counted each day of the week .Broth only culturesQ23. How do I interpret ‘broth only’ for the final culture report when reporting infection events in NHSN?Q18. How do I interpret ‘broth only’ for the final culture report when reporting infection events in NHSN?Positive cultures from broth only are considered a positive culture result and treated as such for surveillance purposes. Such media can be enriched to identify organisms that might otherwise be missed.Positive cultures from broth only are considered a positive culture result and treated as such for surveillance purposes . Such media can be enriched to identify organisms that might otherwise be missed.NHSN requirements and recommendation for application useQ24. What is the best Operating System and browser to use with NHSN?Q19. What is the best Operating System and browser to use with NHSN?Please see NHSN’s Requirements and Recommendations on usage NHSN’s Requirements and Recommendations.Please see NHSN’s Requirements and Recommendations on usage : https://www.cdc.gov/nhsn/faqs/faq_general.htmlQ25. Sometimes I have errors in entering data.Try logging completely out of the application. Close your browser, clear your cookies. (Go to Tools, Internet options, then delete, check off cookies, etc.) Instead of using Internet Explorer please try using Microsoft Edge or Google Chrome. Attempt to enter data again. If you continue to have issue, contact NHSN@cdc.gov.Gross anatomicalQ26. What is acceptable evidence of infection found on gross anatomical exam?Gross anatomic evidence of infection is evidence of infection elicited or visualized on physical examination or observed during an invasive procedure. This includes findings elicited on physical examination of a patient during admission or subsequent assessments of the patient and may include findings noted during a medical/invasive procedure, dependent upon the location of the infection as well as the NHSN infection criterion.Examples:* An intraabdominal abscess will require an invasive procedure to actually visualize the abscess.* Visualization of pus or purulent drainage (includes from a drain).* SSI only: Abdominal pain or tenderness post Cesarean section (CSEC) or hysterectomy (HYST or VHYS) is sufficient gross anatomic evidence of infection without an invasive procedure to meet general Organ/Space SSI criterion ‘c’ when a Chapter 17 [PDF – 621 KB] Reproductive Tract infection criteria is met. Allowing the documentation of abdominal pain or tenderness as gross anatomic evidence of infection to meet general Organ/Space SSI criterion ‘c’ enables the user to report an SSI-OREP, SSI-EMET, or SSI-VCUF event. Note that abdominal pain or tenderness cannot be applied as ‘other evidence of infection on gross anatomic exam’ to meet Deep Incisional SSI criterion ‘c’ or to meet any Chapter 17 [PDF – 621 KB] site-specific criterion (for example, OREP ‘2’).Note: Imaging test evidence of infection cannot be applied to meet gross anatomic evidence of infection. Imaging test evidence has distinct findings in the HAI definitions (for example, IAB ‘3b’).Imaging test findingsQ27. Is ‘free fluid’ on an imaging test sufficient to identify infection? Is a ‘fluid collection’ imaging finding sufficient for the ‘infection identified on imaging’ element?Q20. Is ‘free fluid’ on an imaging test sufficient to identify infection? Is a ‘fluid collection’ imaging finding sufficient for the ‘infection identified on imaging’ element?For NHSN surveillance purposes, an imaging finding of ‘free fluid’ is not definitive or equivocal for an NHSN infection criterion. ‘Free fluid’ is not indicative of an infectious process and is considered a negative imaging finding. However, a ‘fluid collection’ imaging finding could be indicative of infection (such as an abscess or early formation of an abscess) and therefore is considered an equivocal imaging finding and eligible to cite an NHSN site-specific infection if clinical correlation is also present. Clinical correlation is physician documentation of antimicrobial treatment for site-specific infection related to equivocal findings (not clearly identified) of infection on imaging test.For NHSN surveillance purposes, an imaging finding of ‘ free fluid ’ is not definitive or equivocal for an NHSN infection criterion – it is considered a negative imaging finding . A ‘ fluid collection ’ imaging finding could be indicative of infection (such as an abscess or early formation of an abscess) and therefore is considered an equivocal imaging finding and eligible to cite an NHSN site-specific infection if clinical correlation is also present . Clinical correlation is physician documentation of antimicrobial treatment for the site-specific infection related to equivocal findings (not clearly identified ) of infection on imaging test.Pathogen reporting in NHSNQ28. How should I assign different organisms for a site-specific infection? What is the proper order for reporting pathogens?Q21. How should I assign different organisms for a site-specific infection? What is the proper order for reporting pathogens?Up to three pathogens may be reported. If multiple pathogens are identified, enter the pathogen judged to be the most important cause of infection as #1, the next most as #2, and the least as #3 (usually this order is indicated on the laboratory report). If the species is not given on the lab report or is not found on the NHSN drop down list, then select the genus only. (Report all site-specific pathogens before secondary BSI pathogens).Up to three pathogens may be reported. If multiple pathogens are identified , enter the pathogen judged to be the most important cause of infection as #1, the next most as #2, and the least as #3 (usually this order is indicated on the laboratory report). If the species is not given on the lab report or is not found on the NHSN terminology browser drop down list , then select the genus only . (Report all site-specific pathogens before secondary BSI pathogens) . It is not possible to include every organism on the NHSN organism list, therefore, it is possible for your laboratory to identify an organism that cannot be found when referencing the NHSN Organism List. DO NOT assume that such an organism is not eligible for a CLABSI event but instead, contact NHSN via ServiceNow . Access ServiceNow at https://servicedesk.cdc.gov/nhsncsp . If you do not have a SAMS login, or are unable to access ServiceNow, you can still email the NHSN Help Desk at nhsn@cdc.gov .Additional pathogens recovered during the Repeat Infection Timeframe (RIT) from the same type of infection are added to the event. Example: Patient admitted 1/1/23 meeting criteria of Symptomatic Urinary Tract Infection (SUTI), urine culture = E. coli >100,000 CFU/ml. On 1/12 another urine culture shows K. pneumoniae >100,000 CFU/ml. The assignment is SUTI – E. coli and K. pneumonia. The exception to this is that excluded organisms for a specific type of infection cannot be added to that type of infection. For example, Candida albicans cannot be added to a previously reported UTI, as Candida is an excluded pathogen for UTI.Q22. The tables of instruction define confirmed COVID as “a patient with a positive COVID-19 (SARS CoV-2) laboratory viral test indicating current infection.” How does this apply to patients that had a positive COVID test in the recent past (say, <30 days) that are no longer testing positive, but are clearly still suffering from their infection? For example, patients with continuing respiratory failure caused by COVID who still require hospitalization but have subsequently tested negative and therefore do not have a test indicating “current” infection – should they be entered as COVID-19 = yes? What about the opposite situation where a patient has an asymptomatic COVID “infection,” and their recent positive test finding was incidental – should they also be entered as COVID-19 = yes?Protocols for Patient Safety Component ModulesThe COVID-19 question is required for all HAI events and is intended to gather data on HAIs related to the COVID-19 condition. To reduce subjectivity, the lab finding of the most recent COVID-19 viral test prior to or on the date of event (HAI) should be used for the response.Q29. Is there a shortcut to finding the major category NHSN protocols?* Answer COVID-19 as ‘YES’ if the patient is lab test confirmed COVID-19 prior to or on the date of event (HAI). Keep in mind that patients may undergo repeat testing post-treatment and may move from a ‘confirmed’ to ‘negative’ COVID-19 status.* Answer COVID-19 as ‘NO’ if the most recent lab test prior to or on the date of event (HAI) is negative.* Chapter 4 – BSI [PDF – 1 MB]* Chapter 6 – PNEU [PDF – 1 MB]* Chapter 7 – UTI [PDF – 1 MB]* Chapter 9 – SSI [PDF – 1 MB]* Chapter 10 – VAE [PDF – 2 MB]* Chapter 11 – PedVAE [PDF – 1 MB]Q30. The tables of instruction define confirmed COVID as “a patient with a positive COVID-19 (SARS CoV-2) laboratory viral test indicating current infection.” How does this apply to patients that had a positive COVID test in the recent past (say, <30 days) that are no longer testing positive, but are clearly still suffering from their infection? For example, patients with continuing respiratory failure caused by COVID who still require hospitalization but have subsequently tested negative and therefore do not have a test indicating “current” infection – should they be entered as COVID-19 = yes? What about the opposite situation where a patient has an asymptomatic COVID “infection,” and their recent positive test finding was incidental – should they also be entered as COVID-19 = yes?* The COVID-19 question is required for all HAI events occurring on or after January 1, 2022 and is intended to gather data on HAIs related to the COVID-19 condition. To reduce subjectivity, the lab finding of the most recent COVID-19 viral test prior to or on the date of event (HAI) should be used for the response.+ Answer COVID-19 as ‘YES’ if the patient is lab test confirmed COVID-19 prior to or on the date of event (HAI). Keep in mind that patients may undergo repeat testing post-treatment and may move from a ‘confirmed’ to ‘negative’ COVID-19 status.+ Answer COVID-19 as ‘NO’ if the most recent lab test prior to or on the date of event (HAI) is negative.We did not include in our definition a length of time for the patient to be considered ‘confirmed’; however, we focus strictly on the current hospitalization and the response should be based on the lab test available within the current patient record.It is our hope that the data received over time will enable us to identify the risk of the COVID-19 condition on HAIs.Event detail – With no other recognized causeQ23. What is meant by “with no other recognized cause” * seen next to some signs and symptoms?“With no other recognized cause” means the sign/symptom is eligible for use in meeting the NHSN infection criteria unless there is physician documentation within the medical record that specifically states the sign/symptom is due to a condition other than the one under investigation. The determination to exclude a sign/symptom with no other recognized cause must be made by the local facility based on the documentation available in the medical record.TrainingNewsletters / Members Meeting UpdatesE-mail UpdatesHealth Department HAI/AR ProgramsLast Reviewed: July 31, 2023Last Reviewed: December 23, 2024Source: Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Healthcare Quality Promotion (DHQP)* Syndicatehome NHSN Home* NHSN Login* About NHSN plus icon+ NHSN’s Stated Purposes+ About NHSN Help Desk+ NHSN Administrator Training+ Data Use Agreements (DUA) with NHSN+ DUA FAQs for Health Departments and Facilities+ FAQs About NHSN Agreement to Participate and Consent+ NHSN Release Management+ FAQs About NHSN+ About SAMS+ SAMS NHSN User FAQs+ FAQs About NHSN Security* Enroll Facility Here plus icon+ Acute Care Hospitals/Facilities plus icono Set-up+ Ambulatory Surgery Centers plus icono Set-up+ Blood Safety Surveillance plus icono Set-up+ Long-term Acute Care Facilities plus icono Set-up+ Inpatient Rehabilitation Facilities plus icono Set-up+ Inpatient Psychiatric Facilities plus icono Set-up+ Long-term Care Facilities plus icono Set-up+ Outpatient Dialysis Facilities plus icono Set-up+ Home Dialysis Facilities+ FAQs About Enrollment* CMS Requirements plus icon+ Acute Care Hospitals (ACH)+ Inpatient Rehabilitation Facilities (IRF)+ Long-term Acute Care Facilities (LTACH)+ Long-term Care Facilities+ PPS Exempt Cancer Hospitals+ Outpatient Dialysis Facilities+ CDC and CMS Issue Joint Reminder on NHSN Reporting+ FAQs About CMS Quality Reporting Programs+ FAQs About CMS Promoting Interoperability Program+ FAQs About NHSN and CMS ESRD QIP Rule* Change NHSN Facility Admin* Resources by Facility plus icon+ COVID-19 Information plus icono Hospital Respiratory Data Dashboardo Nursing Home Vaccination Data Dashboardo Nursing Home Data Dashboardo Dialysis COVID-19 Data Dashboardo Dialysis Vaccination Data Dashboardo FAQs on Transition of COVID-19 Hospital Reportingo Archived COVID-19/Respiratory Pathogens and Vaccination Materials+ Acute Care / Critical Access Hospitals+ Ambulatory Surgery Centers plus icono Newsletters & Archived Communications+ Long-term Acute Care Hospitals+ Inpatient Rehabilitation Facilities+ Inpatient Psychiatric Facilities* Patient Safety Component plus icon+ Nurse Staffing Hours Indicator+ Annual Surveys, Locations & Monthly Reporting Plans+ Analysis Resources plus icono Analysis Quick Reference Guideso Adjusted Ranking Metric (ARM)o Keys to Success with the SIRo Keys to Success with the SAARo Keys to Success with TASo Data Quality+ HAI Rebaseline plus icono Charting the Courseo Progress Trackero Education & Analysis Resourceso Archived Communications+ Antimicrobial Use & Resistance plus icono AU Option Case Examples plus icon- Disseminating Quarterly Data Quality Reports- Tracking Multiple Interventions- Reducing Fluoroquinolone Use- Reducing Carbapenem Use- Reducing Aztreonam Use+ BSI (CLABSI)+ CLIP+ MDRO & CDI+ PedVAE+ PNEU+ SSI+ UTI (CAUTI)+ VAE+ Frequently Asked Questions (FAQs) plus icono Annual Surveyso Bloodstream Infection (BSI) Eventso Central Line Insertion Practices (CLIP)o Pneumonia (PNEU) Eventso Urinary Tract Infection (UTI) Eventso Surgical Site Infections (SSI) Eventso Surgical Site Procedure Codeso Ventilator-Associated (VAE) Eventso Pediatric Ventilator-Associated Events (PedVAE)o Antimicrobial Use (AU) Optiono Antimicrobial Resistance (AR) Optiono MDRO & CDIo Nurse Staffing Hours Indicator (NSHI)o Analysiso Locationso Miscellaneous+ Calculators & Worksheets plus icono HAI & POA Worksheet Generatoro MDRO & CDI LabID Event Calculatoro PedVAE Calculatoro VAE Calculator+ HAI Checklists+ Hospital Respiratory Data* Long-term Care Facility Component plus icon+ Respiratory Pathogens and Vaccination Module plus icon+ Respiratory Pathogens Module plus icono Covid-19 Module Enrollmento Point of Careo RPV Resourceso RP Resources+ Nursing Home Data Dashboard+ State Veterans Homes COVID-19 Tool+ MDRO & CDI+ UTI+ Prevention Process Measures+ HCP Flu Vaccination+ LTCF Data Validation Guidance+ Newsletters & Archived Communicationso December 2020 LTCF Newslettero July 2020 LTCF Newslettero March 2020 LTCF Newslettero December 2019 LTCF Newslettero September 2019 LTCF Newslettero June 2019 LTCF Newslettero March 2019 LTCF Newslettero 2018 LTCF Email Updateso December 2018 LTCF Newslettero September 2018 LTCF Newslettero June 2018 LTCF Newslettero March 2018 LTCF Newslettero 2017 LTCF Email Updateso December 2017 LTCF Newslettero September 2017 LTCF Newsletter* Dialysis Component plus icon+ Dialysis COVID-19 Module+ Patient COVID-19 Vaccination+ Dialysis Event plus icono Dialysis Event Reporting FAQs+ Prevention Process Measures+ CLIP Adherence+ Monthly Newsblast Archive* Biovigilance Component plus icon+ Blood Safety+ Hemovigilance Module FAQs* Healthcare Personnel Safety Component (HPS) plus icon+ HCP Flu Vaccination+ HCP Exposure+ HCP COVID-19 Vaccination+ COVID-19 Vaccination Data FAQs+ Weekly Influenza Vaccination Data Reporting FAQs+ HCP Influenza Vaccination Summary Reporting FAQs plus icono Newsletters & Archived Communications* Neonatal Component plus icon+ Quick Reference Guides+ LOS/MEN Events+ LOS/MEN FAQs* Outpatient Procedure Component plus icon+ SSI+ Same Day Outcome Measures+ Frequently Asked Questions (FAQs)+ Newsletters & Archived Communications* NHSN and Social Determinants of Health* NHSNCoLab* NHSN Digital Quality Measures (dQMs) plus icon+ About FHIR and NHSNLink+ Digital Quality Measures (dQMs) FAQs* NHSN Reports plus icon+ Coronavirus Disease - 2019 (COVID-19)+ HAI Progress Reports+ HAI Pathogens and Antimicrobial Resistance (AR)+ Antibiotic Use and Resistance (AUR) Module+ Long-term Care Facility (LTCF)+ Patient Safety Annual Facility Survey+ Device-Associated (DA) Module Data Summary+ HCP Influenza Vaccination+ Dialysis Event+ Miscellaneous* Group Users* Newsletters* Data Validation Guidance plus icon+ 2023+ 2022+ 2021+ Validation FAQs+ Archived Validation Documents* Email Updates* Quality Measure Endorsement* HIPAA Privacy Rule plus icon+ Facility/Provider Communications Under HIPAAemail_03 Get Email UpdatesTo receive email updates about this page, enter your email address:Email AddressWhat's this?SubmitNHSN HelpdeskQuestions about NHSN?Contact us: nhsn@cdc.govManuals & Protocols*+o 2023 LTCF Resident Weekly COVID-19/Respiratory Pathogens Vaccination Module Protocol [PDF – 414 KB]o 2025 Patient Safety Component Manual [PDF – 8 MB]o 2024 Patient Safety Component Manual [PDF – 8 MB]o 2023 Patient Safety Component Manual [PDF – 7 MB]o 2024 Long-term Care Facility Manual [PDF – 2 MB]o 2024 Outpatient Procedure Component Manual [PDF – 1 MB]o 2025 Outpatient Procedure Component Manual [PDF – 1 MB]o 2023 Outpatient Procedure Component Manual [PDF – 1 MB]o 2024 Outpatient Procedure Component Manual [PDF – 1,002 KB]o Coming Soon: 2023 Healthcare Personnel Safety Component Manualo 2025 HCP Weekly COVID-19 Vaccination Module Protocol [PDF – 359 KB]o 2024 HCP Weekly COVID-19 Vaccination Module Protocol [PDF – 350 KB]o 2023 HCP Weekly COVID-19 Vaccination Module Protocol [PDF – 348 KB]o 2022 HCP Weekly COVID-19 Vaccination Module Protocol [PDF – 348 KB]o 2025 Dialysis Patient Weekly COVID-19 Vaccination Module Protocol [PDF – 292 KB]o 2023 Dialysis Patient Weekly COVID-19 Vaccination Module Protocol [PDF – 382 KB]o 2023 Combined LTCF Resident and Dialysis Patient Weekly COVID-19 Vaccination Module Protocol [PDF – 421 KB]o 2025 HCP Vaccination Module: Influenza Vaccination Summary Protocol [PDF – 350 KB]o 2022 HCP Vaccination Module: Influenza Vaccination Summary Protocol [PDF – 596 KB]o 2021 Biovigilance Component Protocol [PDF – 600 KB]* About CDC* Contact Us* 800-232-4636Facebook Twitter Instagram LinkedIn Youtube Pinterest SnapchatFacebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat RSS* CONTACT CDCContact UsCall 800-232-4636Email Us* ABOUT CDC+ About CDC+ Jobs+ Funding* POLICIES+ Accessibility+ External Links+ Privacy+ Policies+ Web Policies+ No Fear Act+ FOIA+ OIG+ No Fear Act+ Nondiscrimination+ Vulnerability Disclosure Policy+ CDC Archive+ Public Health Publications+ HHS.gov+ USA.gov* CONNECT WITH US+ Youtube+ Snapchat* LANGUAGES+ Español+ 繁體中文+ Tiếng Việt+ 한국어+ Tagalog+ Русский+ العربية+ Kreyòl Ayisyen+ Français+ Polski+ Português+ Italiano+ Deutsch+ 日本語+ فارسی+ English* U.S. Department of Health & Human Services* Accessibility* External Links* Privacy* Policies* Web Policies* FOIA* OIG* No Fear Act* FOIA* Nondiscrimination* OIG* Vulnerability Disclosure Policy* CDC Archive* Public Health Publications* HHS.gov* USA.govContent Credential×This image was edited or created using GenAI (generative artificial intelligence).Our experts review all images in an effort to ensure accuracy and quality before use.Learn more about CDC's usage of GenAI.
Note: Comparison ignores leading/trailing whitespace
and certain script/tracking codes. Word-level
highlighting (optional above) only applies to changed
lines.